Recent investigations have converged on the convergence of GLP|GIP|glucagon receptor activator therapies and dopaminergic communication. While GLP stimulators are widely employed for managing type 2 T2DM, their unexpected consequences on motivation circuits, specifically influenced by dopamine pathways, are receiving considerable focus. This articl